These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
634 related articles for article (PubMed ID: 19609474)
1. Adapalene 0.1% and benzoyl peroxide 2.5%: a novel combination for treatment of acne vulgaris. Tan JK Skin Therapy Lett; 2009; 14(6):4-5. PubMed ID: 19609474 [TBL] [Abstract][Full Text] [Related]
2. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients. Gollnick HP; Draelos Z; Glenn MJ; Rosoph LA; Kaszuba A; Cornelison R; Gore B; Liu Y; Graeber M; Br J Dermatol; 2009 Nov; 161(5):1180-9. PubMed ID: 19466959 [TBL] [Abstract][Full Text] [Related]
3. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study. Gonzalez P; Vila R; Cirigliano M J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047 [TBL] [Abstract][Full Text] [Related]
4. A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne. Gold LS; Tan J; Cruz-Santana A; Papp K; Poulin Y; Schlessinger J; Gidner J; Liu Y; Graeber M; Cutis; 2009 Aug; 84(2):110-6. PubMed ID: 19746769 [TBL] [Abstract][Full Text] [Related]
5. Adapalene-benzoyl peroxide once-daily, fixed-dose combination gel for the treatment of acne vulgaris: a randomized, bilateral (split-face), dose-assessment study of cutaneous tolerability in healthy participants. Andres P; Pernin C; Poncet M Cutis; 2008 Mar; 81(3):278-84. PubMed ID: 18441854 [TBL] [Abstract][Full Text] [Related]
6. Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study. Thiboutot DM; Weiss J; Bucko A; Eichenfield L; Jones T; Clark S; Liu Y; Graeber M; Kang S; J Am Acad Dermatol; 2007 Nov; 57(5):791-9. PubMed ID: 17655969 [TBL] [Abstract][Full Text] [Related]
7. Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged ≥ 12 years. Keating GM Am J Clin Dermatol; 2011 Dec; 12(6):407-20. PubMed ID: 21967116 [TBL] [Abstract][Full Text] [Related]
8. The efficacy, safety and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris; a randomized trial. Babaeinejad SH; Fouladi RF J Drugs Dermatol; 2013 Sep; 12(9):1033-8. PubMed ID: 24002152 [TBL] [Abstract][Full Text] [Related]
9. The efficacy, safety, and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris: a randomized trial. Babaeinejad SH; Fouladi RF J Drugs Dermatol; 2013 Jul; 12(7):790-4. PubMed ID: 23884492 [TBL] [Abstract][Full Text] [Related]
10. Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides. Eichenfield LF; Draelos Z; Lucky AW; Hebert AA; Sugarman J; Stein Gold L; Rudisill D; Liu H; Manna V J Drugs Dermatol; 2013 Jun; 12(6):611-8. PubMed ID: 23839175 [TBL] [Abstract][Full Text] [Related]
11. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris. Langner A; Chu A; Goulden V; Ambroziak M Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518 [TBL] [Abstract][Full Text] [Related]
12. Treatment of 2,453 acne vulgaris patients aged 12-17 years with the fixed-dose adapalene-benzoyl peroxide combination topical gel: efficacy and safety. Eichenfield LE; Jorizzo JL; Dirschka T; Taub AF; Lynde C; Graeber M; Kerrouche N J Drugs Dermatol; 2010 Nov; 9(11):1395-401. PubMed ID: 21061762 [TBL] [Abstract][Full Text] [Related]
13. Dapsone gel 5% in combination with adapalene gel 0.1%, benzoyl peroxide gel 4% or moisturizer for the treatment of acne vulgaris: a 12-week, randomized, double-blind study. Fleischer AB; Shalita A; Eichenfield LF; Abramovits W; Lucky A; Garrett S; J Drugs Dermatol; 2010 Jan; 9(1):33-40. PubMed ID: 20120423 [TBL] [Abstract][Full Text] [Related]
14. Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study. Stein Gold L; Weiss J; Rueda MJ; Liu H; Tanghetti E Am J Clin Dermatol; 2016 Jun; 17(3):293-303. PubMed ID: 26945741 [TBL] [Abstract][Full Text] [Related]
15. Digital videography assessment of patients' experiences using adapalene-benzoyl peroxide gel in the treatment of acne vulgaris. Feldman SR; Fried RG; Herndon JH; Johnson L; Preston N; Gottschalk RW; Caveney SW J Drugs Dermatol; 2012 Aug; 11(8):919-25. PubMed ID: 22859236 [TBL] [Abstract][Full Text] [Related]
16. Adapalene 0.1% and benzoyl peroxide 2.5% as a fixed-dose combination gel is as well tolerated as the individual components alone in terms of cumulative irritancy. Loesche C; Pernin C; Poncet M Eur J Dermatol; 2008; 18(5):524-6. PubMed ID: 18693154 [TBL] [Abstract][Full Text] [Related]
17. Study of the efficacy, tolerability, and safety of 2 fixed-dose combination gels in the management of acne vulgaris. Zouboulis CC; Fischer TC; Wohlrab J; Barnard J; Alió AB Cutis; 2009 Oct; 84(4):223-9. PubMed ID: 19911678 [TBL] [Abstract][Full Text] [Related]
18. Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0.1% and benzoyl peroxide 2.5% for the treatment of acne vulgaris. Pariser DM; Westmoreland P; Morris A; Gold MH; Liu Y; Graeber M J Drugs Dermatol; 2007 Sep; 6(9):899-905. PubMed ID: 17941361 [TBL] [Abstract][Full Text] [Related]
19. Adapalene-benzoyl peroxide (Epiduo) for acne. Med Lett Drugs Ther; 2009 Apr; 51(1310):31-2. PubMed ID: 19377407 [No Abstract] [Full Text] [Related]
20. Synergistic efficacy of adapalene 0.1%-benzoyl peroxide 2.5% in the treatment of 3855 acne vulgaris patients. Tan J; Gollnick HP; Loesche C; Ma YM; Gold LS J Dermatolog Treat; 2011 Aug; 22(4):197-205. PubMed ID: 20666678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]